Biomarkers of Alzheimer's disease: F2-isoprostanes

被引：0
|
作者：
Pratico, D [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80015-0
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [1] F2-isoprostanes as biomarkers of late-onset Alzheimer's disease
    Montine, Thomas J.
    Quinn, Joseph
    Kaye, Jeffrey
    Morrow, Jason D.
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2007, 33 (01) : 114 - 119
  • [2] F2-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease
    Thomas J. Montine
    Joseph Quinn
    Jeffrey Kaye
    Jason D. Morrow
    [J]. Journal of Molecular Neuroscience, 2007, 33 : 114 - 119
  • [3] Increased urinary F2-isoprostanes levels in the patients with Alzheimer's disease
    Kim, KM
    Jung, BH
    Paeng, KJ
    Kim, I
    Chung, BC
    [J]. BRAIN RESEARCH BULLETIN, 2004, 64 (01) : 47 - 51
  • [4] Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer's Disease as Identified by Biomarkers
    Montine, Thomas J.
    Peskind, Elaine R.
    Quinn, Joseph F.
    Wilson, Angela M.
    Montine, Kathleen S.
    Galasko, Douglas
    [J]. NEUROMOLECULAR MEDICINE, 2011, 13 (01) : 37 - 43
  • [5] Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers
    Thomas J. Montine
    Elaine R. Peskind
    Joseph F. Quinn
    Angela M. Wilson
    Kathleen S. Montine
    Douglas Galasko
    [J]. NeuroMolecular Medicine, 2011, 13 : 37 - 43
  • [6] Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease
    Montine, TJ
    Quinn, JF
    Milatovic, D
    Silbert, LC
    Dang, T
    Sanchez, S
    Terry, E
    Roberts, LJ
    Kaye, JA
    Morrow, JD
    [J]. ANNALS OF NEUROLOGY, 2002, 52 (02) : 175 - 179
  • [7] F2-isoprostanes: sensitive biomarkers of oxidative stress
    Wiswedel, I.
    [J]. FREE RADICAL RESEARCH, 2008, 42 : S42 - S42
  • [8] F2-isoprostanes in Alzheimer and other neurodegenerative diseases
    Montine, TJ
    Montine, KS
    McMahan, W
    Markesbery, WR
    Quinn, JF
    Morrow, JD
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (1-2) : 269 - 275
  • [9] Increased F2-isoprostanes in Alzheimer's disease:: evidence for enhanced lipid peroxidation in vivo
    Praticò, D
    Lee, VMY
    Trojanowski, JQ
    Rokach, J
    Fitzgerald, GA
    [J]. FASEB JOURNAL, 1998, 12 (15): : 1777 - 1783
  • [10] No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls
    Montine, TJ
    Shinobu, L
    Montine, KS
    Roberts, LJ
    Kowall, NW
    Beal, MF
    Morrow, JD
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (06) : 950 - 950
12345